Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
Add more filters










Publication year range
1.
Infect Genet Evol ; 50: 1-6, 2017 06.
Article in English | MEDLINE | ID: mdl-28189886

ABSTRACT

Pestiviruses of cattle include bovine viral diarrhoea 1 (BVDV-1) and 2 (BVDV-2) plus an emerging group, named HoBi-like pestivirus. In the present paper, the results of an epidemiological survey for pestiviruses circulating in cattle in southern Italy are presented. Molecular assays carried out on a total of 924 bovine samples detected 74 BVDV strains, including 73 BVDV-1 and 1 BVDV-2 viruses. Phylogenetic analysis carried out on partial 5'UTR and Npro sequences revealed the presence of 6 different subtypes of BVDV-1 and a single BVDV-2c strain. BVDV-1 displayed a high level of genetic heterogeneity, which can have both prophylactic and diagnostic implications. In addition, the detection of BVDV-2c highlights the need for a continuous surveillance for the emergence of new pestivirus strains in cattle farms in southern Italy.


Subject(s)
Bovine Virus Diarrhea-Mucosal Disease/epidemiology , Cattle Diseases/epidemiology , Diarrhea Virus 1, Bovine Viral/genetics , Diarrhea Virus 2, Bovine Viral/genetics , Pestivirus/genetics , Phylogeny , Animals , Bovine Virus Diarrhea-Mucosal Disease/pathology , Bovine Virus Diarrhea-Mucosal Disease/transmission , Bovine Virus Diarrhea-Mucosal Disease/virology , Cattle , Cattle Diseases/pathology , Cattle Diseases/transmission , Cattle Diseases/virology , Diarrhea Virus 1, Bovine Viral/classification , Diarrhea Virus 1, Bovine Viral/isolation & purification , Diarrhea Virus 2, Bovine Viral/classification , Diarrhea Virus 2, Bovine Viral/isolation & purification , Epidemiological Monitoring , Female , Genetic Heterogeneity , Italy/epidemiology , Lung/pathology , Lung/virology , Pestivirus/classification , Pestivirus/isolation & purification , Placenta/pathology , Placenta/virology , Pregnancy , Spleen/pathology , Spleen/virology
2.
Transbound Emerg Dis ; 64(6): 1935-1944, 2017 Dec.
Article in English | MEDLINE | ID: mdl-27878974

ABSTRACT

Recently, bovine viral diarrhoea virus type 2c (BVDV-2c) was responsible for a severe outbreak in cattle in northern Europe. Here, we present the results of an epidemiological survey for pestiviruses in ruminants in southern Italy. Pooled serum samples were obtained from 997 bovine, 800 ovine, 431 caprine and eight bubaline farms, and pestiviral RNA was detected by molecular methods in 44 farms consisting of 16 cattle and one buffalo herds and of 21 sheep and six goat flocks. Twenty-nine and 15 farms were infected by BVDV-1 and BVDV-2 strains, respectively. BVDV-1 strains were recovered mainly from cattle and were heterogeneous, belonging to the subtypes 1b, 1u, 1e, 1g and 1h. In contrast, all BVDV-2 viruses but two were detected in sheep or goats and were characterized as BVDV-2c by sequence analysis of 5'UTR. These strains displayed high genetic identity to BVDV-2c circulating in cattle in northern Europe and were more distantly related to a BVDV-2c isolate recovered from a cattle herd in southern Italy more than 10 years before. The circulation of a BVDV-2c in small ruminants suggests the need for a continuous surveillance for the emergence of pestivirus-induced clinical signs in southern Italian farms.


Subject(s)
Diarrhea Virus 2, Bovine Viral/isolation & purification , Goat Diseases/epidemiology , Pestivirus Infections/veterinary , Sheep Diseases/epidemiology , 5' Untranslated Regions , Animals , Diarrhea Virus 1, Bovine Viral/classification , Diarrhea Virus 1, Bovine Viral/isolation & purification , Diarrhea Virus 2, Bovine Viral/classification , Goat Diseases/virology , Goats , Italy/epidemiology , Pestivirus Infections/epidemiology , Pestivirus Infections/virology , Phylogeny , RNA, Viral/analysis , Sheep , Sheep Diseases/virology
3.
Transbound Emerg Dis ; 63(5): 469-73, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27390140

ABSTRACT

The clinical features and economic impact of the infection caused by an emerging group of pestiviruses, namely HoBi-like pestivirus, in a cattle herd of southern Italy are reported. In 2011, the virus was first associated with respiratory disease, causing an abortion storm after 1 year and apparently disappearing for the following 3 years after persistently infected calves were slaughtered. However, in 2014, reproductive failures and acute gastroenteritis were observed in the same herd, leading to a marked decrease of productivity. A HoBi-like strain closely related to that responsible for previous outbreaks was detected in several animals. Application of an intensive eradication programme, based on the detection and slaughtering of HoBi-like pestivirus persistently infected animals, resulted in a marked improvement of the productive performances.


Subject(s)
Cattle Diseases/virology , Pestivirus Infections/veterinary , Abortion, Veterinary , Animals , Cattle , Disease Outbreaks , Female , Gastroenteritis/virology , Italy , Pregnancy
4.
J Intraven Nurs ; 21(2): 101-4, 1998.
Article in English | MEDLINE | ID: mdl-9601317

ABSTRACT

This article describes some of the major causes of stress for nurses and other professional care givers who work with the dying, their families, and the bereaved. It specifically addresses the stress of cumulative grief in the work situation and its effects on the care giver. It also describes some of the strategies for the institution and the individual nurse that can be used to minimize the effects of stress and cumulative grief and can contribute to emotional health in this type of work.


Subject(s)
Burnout, Professional/psychology , Grief , Nursing Staff/psychology , Terminal Care , Adaptation, Psychological , Humans , Social Support
5.
In Vitro Cell Dev Biol Anim ; 30A(9): 615-21, 1994 Sep.
Article in English | MEDLINE | ID: mdl-7820313

ABSTRACT

Over-expression of transforming growth factor-alpha (TGF-alpha) is consistently seen in spontaneous transformants of rat liver derived epithelial cells (RLE phi 13) and has been implicated in the transformation of other cultured cells. We have constitutively over-expressed TGF-alpha in RLE phi 13 cells, which are known to express epidermal growth factor receptors, to determine if TGF-alpha over-expression plays a role in transformation or differentiation, or both, of these cells. Early passage RLE phi 13 cells were infected with a replication-defective murine retrovirus that expresses both the full length coding sequence for human TGF-alpha and the neomycin-resistance gene. Integration of the transcriptionally active provirus and expression of TGF-alpha mRNA were confirmed. Neither morphologic transformation nor molecular evidence for differentiation was noted in TGF-alpha-producing clones. However, these clones did exhibit an accelerated growth rate, increased expression of several cell cycle related genes including mitotic cyclic B1, proliferating cell nuclear antigen, c-myc, and p53 as well as increased expression of the preneoplastic marker enzyme, glutathione-S-transferase. This suggests that over-expression of TGF-alpha results in increased cell cycling, and that subsequent events must be necessary for cellular transformation or differentiation or both.


Subject(s)
Cell Cycle , Cell Transformation, Neoplastic , Gene Expression , Liver/metabolism , Transforming Growth Factor alpha/genetics , Animals , Blotting, Southern , Cell Line , Drug Resistance/genetics , Epithelium/metabolism , ErbB Receptors/genetics , Liver/cytology , Mice , Mice, Nude , Neomycin , RNA, Messenger/metabolism , Rats , Retroviridae/genetics , Transfection
6.
Hepatology ; 17(5): 854-60, 1993 May.
Article in English | MEDLINE | ID: mdl-8098315

ABSTRACT

P-glycoprotein, an energy-dependent plasma membrane drug-efflux pump capable of reducing the intracellular concentration of a variety of hydrophobic xenobiotics, is encoded by mdr1, a member of the multidrug-resistant (mdr) gene family. The physiological function of this protein is unknown. Because of its location on the bile canalicular domain of the hepatocyte, we and others have hypothesized that P-glycoprotein may have a physiological role as a biliary transporter of xenobiotics and endobiotics and that its expression may therefore be altered in cholestasis. Both obstructive and alpha-naphthylisothiocyanate-induced cholestasis increased mdr1a and 1b gene expression in rat liver. Hepatic P-glycoprotein levels were also increased, and the protein remained localized at the biliary hepatocyte domain. Induction of mdr1a and mdr1b gene expression in rat liver was accomplished by means of increased transcription. alpha-Naphthylisothiocyanate-induced cholestasis in cynomolgus monkeys increased hepatic expression of both the mdr1 and 2 genes. To investigate the possible role of P-glycoprotein as a biliary efflux transporter, biliary excretion of vinblastine, a representative substrate of P-glycoprotein, was studied in rats. Increased hepatic mdr messenger RNA and P-glycoprotein levels, mediated by the xenobiotic inducer 2-acetylaminofluorene, resulted in a significant increase in biliary excretion of vinblastine, which was antagonized by the P-glycoprotein inhibitor verapamil. These findings suggest that P-glycoprotein functions as a biliary efflux pump for xenobiotics and, possibly, for unidentified physiological inducers that may mediate increased transcription of the mdr gene observed during cholestasis.


Subject(s)
Carrier Proteins/genetics , Cholestasis/genetics , Drug Resistance/genetics , Gene Expression Regulation , Membrane Glycoproteins/genetics , ATP Binding Cassette Transporter, Subfamily B, Member 1 , Animals , Bile/metabolism , Blotting, Northern , Blotting, Western , Carrier Proteins/physiology , Female , Immunohistochemistry , Macaca fascicularis , Male , Membrane Glycoproteins/physiology , Rats , Rats, Inbred F344 , Vinblastine/metabolism
7.
Cancer Res ; 53(8): 1719-23, 1993 Apr 15.
Article in English | MEDLINE | ID: mdl-8467484

ABSTRACT

Double transgenic mice bearing fusion genes consisting of mouse albumin enhancer/promoter-mouse c-myc complementary DNA and mouse metallothionein 1 promoter-human transforming growth factor alpha complementary DNA were generated to investigate the interaction of these genes in hepatic oncogenesis and to provide a general paradigm for characterizing the interaction of nuclear oncogenes and growth factors in tumorigenesis. Coexpression of c-myc and transforming growth factor alpha as transgenes in the mouse liver resulted in a tremendous acceleration of neoplastic development in this organ as compared to expression of either of these transgenes alone. The two distinct cellular reactions that occurred in the liver of the double transgenic mice prior to the appearance of liver tumors were dysplastic and apoptotic changes in the existing hepatocytes followed by emergence of multiple focal lesions composed of both hyperplastic and dysplastic cell populations. These observations suggest that the interaction of c-myc and transforming growth factor alpha, and possibly other combinations of nuclear oncogenes and growth factors, during development of hepatic neoplasia contributes to the selection and expansion of the preneoplastic cell populations which consequently increases the probability of malignant conversion.


Subject(s)
Cocarcinogenesis , Genes, myc , Liver Neoplasms, Experimental/genetics , Transforming Growth Factor alpha/genetics , Animals , Cell Nucleus/metabolism , Cell Transformation, Neoplastic/genetics , Disease Models, Animal , Gene Expression , Male , Mice , Mice, Transgenic , Zinc/pharmacology
8.
J Bacteriol ; 173(10): 3128-33, 1991 May.
Article in English | MEDLINE | ID: mdl-1708761

ABSTRACT

The uncoupler 2,4-dinitrophenol prevents in vivo synthesis of O antigen in Salmonella typhimurium by inhibiting the first reaction of the pathway, formation of galactosyl-pyrophosphoryl-undecaprenol. Inhibition was observed only in intact cells; dinitrophenol had no effect on activity of the synthase enzyme in isolated membrane fractions. In vivo inhibition could not be explained by changes in intracellular nucleotide pools or a shift in the equilibrium of the reaction and appeared to be specific for the first step in the pathway. Neither the subsequent mannosyl transferase, which catalyzes formation of the trisaccharide-lipid intermediate, mannosyl-rhamnosyl-galactosyl-pyrophosphoryl-undecaprenol, nor O-antigen polymerase was inhibited. In addition, incorporation of galactose into core lipopolysaccharide was only modestly inhibited under conditions in which O-antigen synthesis was abolished. The results suggest that maintenance of proton motive force is required for access of substrate, UDP-galactose and/or undecaprenyl phosphate, to the active site of the galactosyl-pyrophosphoryl-undecaprenol synthase enzyme.


Subject(s)
Antigens, Bacterial/biosynthesis , Salmonella typhimurium/metabolism , Biological Transport, Active , Dinitrophenols/pharmacology , Energy Metabolism , Galactose/metabolism , Hydrogen-Ion Concentration , Lipopolysaccharides/metabolism , Mannose/metabolism , Membrane Potentials , O Antigens , Oligosaccharides/metabolism , Phosphorylation , Salmonella typhimurium/immunology , Terpenes/metabolism , Uridine Monophosphate/metabolism
9.
Pharmacol Ther ; 49(3): 283-92, 1991.
Article in English | MEDLINE | ID: mdl-1675806

ABSTRACT

The data discussed in this review indicate that the coordinated induction of both the mdr gene family and a subfamily of the cytochrome P-450 supergene family provide a unified response of the organism to prevent lethal accumulation of xenobiotics. Consequently, a distinct physiological role for the mdr multigene family now exists. Furthermore, recent evidence suggests the existence of multiple receptors with overlapping substrate specificity that are involved in the induction of both mdr and P-4501A gene families. The increased expression of mdr gene(s) in the early stages of liver carcinogenesis and presumably in other tissues is associated with the development of xenobiotic resistance that is observed in the preneoplastic cell populations. These observations may have important clinical implications and may provide an explanation for resistance to chemotherapy of tumors in organs such as liver and colon that are frequently exposed to both environmental and dietary xenobiotics.


Subject(s)
Carcinogens/pharmacology , Drug Tolerance/genetics , Gene Expression Regulation/physiology , Xenobiotics/pharmacology , ATP Binding Cassette Transporter, Subfamily B, Member 1 , Animals , Membrane Glycoproteins/isolation & purification
10.
Mol Carcinog ; 4(6): 499-509, 1991.
Article in English | MEDLINE | ID: mdl-1686552

ABSTRACT

Previous studies by this laboratory have indicated that expression of the multidrug resistance (mdr) gene can be increased in vivo by exposure to a variety of xenobiotics. Because of the nature of these compounds, it was proposed that mdr gene expression might, at least in part, be regulated by the arylhydrocarbon (Ah) receptor. In the present study, we used a primary hepatocyte culture model to examine the relationship between induction of cytochrome P450IA and mdr expression in vitro. Both 3-methylcholanthrene (MC) and 2-acetylaminofluorene (AAF) were efficient inducers of mdr expression in this model. Induction of mdr gene expression by both MC and AAF obeyed a log10 concentration/response relationship. In contrast, 2,3,7,8-tetrachlorodibenzo-P-dioxin did not induce mdr expression at concentrations that yielded maximum induction of cytochrome P450IA expression. These data suggest that mdr induction was not mediated via the Ah receptor. Nuclear run-off analysis indicated that both AAF and MC induced mdr expression by increasing transcription. Primer extension analysis indicated that mdr gene transcription was initiated at one major site 151 bp upstream of the ATG site in both the uninduced and induced state in vivo and in vitro. The sequence of the primer and the site of initiation of gene transcription indicate that the main gene induced was the mdr 1b gene.


Subject(s)
2-Acetylaminofluorene/pharmacology , Cytochrome P-450 Enzyme System/genetics , Drug Resistance , Liver/physiology , Membrane Glycoproteins/genetics , Methylcholanthrene/pharmacology , Oxidoreductases/genetics , ATP Binding Cassette Transporter, Subfamily B, Member 1 , Animals , Blotting, Northern , Cells, Cultured , Cytochrome P-450 CYP1A2 , Enzyme Induction/drug effects , Gene Expression Regulation/drug effects , In Vitro Techniques , Male , Multigene Family , RNA, Messenger/genetics , Rats , Rats, Inbred F344 , Time Factors , Transcription, Genetic/drug effects
11.
Cell Growth Differ ; 1(2): 57-62, 1990 Feb.
Article in English | MEDLINE | ID: mdl-1982215

ABSTRACT

The MDR1 gene encodes an Mr 170,000 energy-dependent drug efflux pump (P-glycoprotein) which transports hydrophobic agents such as Adriamycin, colchicine, the Vinca alkaloids, and actinomycin D out of cells. Increased expression of the mdr gene has been observed in preneoplastic and neoplastic carcinogen-induced rat liver nodules as well as in regenerating rat liver, suggesting that the mdr gene is regulated in response to liver injury. To determine whether the increased levels of mdr mRNA seen in regenerating liver are the result of an increased rate of transcription or a posttranscriptional event, nuclear run-on assays were performed on nuclei isolated from regenerating rat livers 4-72 h after partial hepatectomy. Whereas Northern blot analysis of regenerating rat liver demonstrated a greater than 20-fold increase in mdr mRNA levels, there was little or no increase in mdr gene transcription as measured by nuclear run-on analyses. beta-Actin and metallothionein gene transcription levels, known to increase transiently in regenerating liver, both showed increased nuclear run-on activity 4 h posthepatectomy, indicating that the nuclei were functional. Failure to demonstrate a substantial increase in mdr gene transcription suggests that the observed increase in mdr mRNA levels may result from a posttranscriptional event such as message stabilization. The sequence of the 3' noncoding region of the MDR1 gene shares strong homology with other unstable mRNAs, suggesting that RNA stabilization could account for the rise of mdr mRNA after partial hepatectomy.


Subject(s)
Carrier Proteins/genetics , Drug Resistance/genetics , Gene Expression Regulation , Liver Regeneration , Liver/metabolism , Membrane Glycoproteins/genetics , ATP Binding Cassette Transporter, Subfamily B, Member 1 , Actins/genetics , Animals , Base Sequence , Biological Transport, Active , Carrier Proteins/biosynthesis , Cytochrome P-450 Enzyme System/genetics , Hepatectomy , Liver/drug effects , Membrane Glycoproteins/biosynthesis , Metallothionein/genetics , Molecular Sequence Data , RNA, Messenger/biosynthesis , Rats , Rats, Inbred F344 , Sequence Homology, Nucleic Acid , Transcription, Genetic
12.
J Biol Chem ; 260(28): 14965-70, 1985 Dec 05.
Article in English | MEDLINE | ID: mdl-3905787

ABSTRACT

Energy inhibitors block translocation of pulse-labeled core lipopolysaccharide to outer membrane under conditions which allow maintenance of constant specific radioactivity of intracellular precursor pools throughout the chase period. Under the conditions used, approximately 75% of the total cellular label was membrane-bound at initiation of chase. Translocation of core lipopolysaccharide from inner to outer membrane showed apparent first order kinetics (t1/2 = 1.2 min, 32 degrees C). Translocation was blocked by arsenate (5-10 mM) under conditions where proton motive force was unchanged, while the uncouplers 2,4-dinitrophenol (0.1 mM to 0.8 mM) and carbonyl cyanide-m-chlorophenyl hydrazone (12-30 microM) inhibited translocation with no apparent effect on the ATP pool. Therefore, core lipopolysaccharide translocation appears to require maintenance of both proton motive force and high energy phosphate pools. Electron microscopic experiments show no gross disruption of zones of adhesion, the putative sites of lipopolysaccharide translocation, in the presence of arsenate or 2,4-dinitrophenol suggesting that energy is not required simply for maintenance of these structures.


Subject(s)
Energy Metabolism , Lipopolysaccharides/metabolism , Salmonella typhimurium/metabolism , 2,4-Dinitrophenol , Arsenates/pharmacology , Carbonyl Cyanide m-Chlorophenyl Hydrazone/pharmacology , Dinitrophenols/pharmacology , Mathematics , Membrane Potentials , Microscopy, Electron , Tetraethylammonium Compounds/pharmacology
13.
Cancer Res ; 43(8): 3633-7, 1983 Aug.
Article in English | MEDLINE | ID: mdl-6861134

ABSTRACT

The degree of activation of peritoneal macrophages elicited by pyran copolymer (MVE-2) was studied in C57BL/6J mice. When cytotoxicity was examined under endotoxin-free culture conditions, the pyran-elicited macrophages could not complete cytolysis of tumor target cells. The macrophages, however, completed cytolysis when pulsed with endotoxin. These results were obtained when either the interval between injection of the pyran copolymer and harvest of the macrophage or the dose of pyran was varied. The pyran-elicited macrophages expressed five markers considered to be typical of inflammatory macrophages, and bound tumor cells to an augmented degree. The pyran-elicited macrophages were capable of secreting a potent cytolytic proteinase when pulsed with endotoxin, but did not secrete cytolytic proteinase spontaneously. The pyran-elicited macrophages, in contrast to inflammatory macrophages, could effect cytostasis of tumor cells; their cytostatic potential was also augmented by addition of endotoxin. Taken together, the results indicated that pyran copolymer elicits primed but not fully activated murine macrophages.


Subject(s)
Macrophage Activation/drug effects , Polymers/pharmacology , Pyran Copolymer/pharmacology , Animals , Cytotoxicity, Immunologic/drug effects , Female , Macrophages/immunology , Mice , Mice, Inbred C57BL
14.
J Immunol ; 131(2): 1038-43, 1983 Aug.
Article in English | MEDLINE | ID: mdl-6306103

ABSTRACT

Murine mononuclear phagocytes in various stages of activation were elicited in vivo or induced in vitro. The cytolytic competence of each type of macrophage, before and after treatment with traces of endotoxin, was quantified. Populations of responsive, primed, and activated macrophages, but not resident macrophages, expressed five markers that have been reported to characterize inflammatory macrophages: increased spreading, increased phagocytosis via Fc and C3 receptors, increased secretion of plasminogen activator, and decreased content of the ectoenzyme 5' nucleotidase. Primed macrophages secreted cytolytic protease (CP) when pulsed with traces of endotoxin; the resident and responsive macrophages did not. The primed macrophages bound tumor cells to a considerable degree; the resident and responsive macrophages did not. The cytolytically activated macrophages bound tumor cells well and secreted lytic protease spontaneously. The capacity for augmented, selective binding of tumor cells is apparently induced in only one step by application of lymphokine(s). The capacity for secreting CP, however, is regulated in two steps; initial priming signals--lymphokine(s)--prepare the macrophages for secretion, and a second signal, such as endotoxin or endotoxin plus tumor cells, triggers the actual release of CP.


Subject(s)
Cytotoxicity, Immunologic , Macrophages/immunology , Neoplasms/immunology , Phagocytosis , 5'-Nucleotidase , Animals , Endotoxins/pharmacology , Female , Macrophage Activation/drug effects , Macrophage-1 Antigen , Mice , Mice, Inbred C57BL , Nucleotidases/analysis , Plasminogen Activators/metabolism , Receptors, Complement/metabolism , Receptors, Fc/metabolism , Receptors, IgG
16.
Eur J Cancer Clin Oncol ; 19(1): 141-7, 1983 Jan.
Article in English | MEDLINE | ID: mdl-6682772

ABSTRACT

Magnetic albumin microspheres (1 micron average diameter) were selectively targeted to subcutaneous solid Yoshida sarcoma tumors (average size 450 mm2) in Holtzman rats. This was accomplished by placing an external magnet adjacent to the tumor while the microspheres were infused. Microspheres contained ultra-fine particles of Fe3O4 and no drug (placebo). Placebo microspheres were used due to the previously demonstrated rapid tumoricidal effect of targeted low-dose doxorubicin microspheres. Animals were killed 10 min, 60 min, 30 min, 24 hr and 72 hr after microsphere administration and tumors were examined by transmission electron microscopy to determine the in vivo disposition of the magnetically targeted microspheres. Using placebo microspheres, we have demonstrated microspheres endocytosed in endothelial cells as early as 10 min after infusion. By 30 min microspheres can be seen in the extravascular compartment, sitting adjacent to tumor cells and occasionally in tumor cells. By 24 hr the majority of microspheres have been endocytosed by tumor cells. Microspheres were still observed within tumor cells as late as 72 hr after administration. The rapid extravasation and cellular uptake of magnetically focused microspheres explains the extremely rapid tumoricidal effect previously observed when doxorubicin-containing microspheres were targeted to the tumor.


Subject(s)
Antineoplastic Agents/administration & dosage , Sarcoma, Yoshida/drug therapy , Animals , Cytoplasm/ultrastructure , Doxorubicin/administration & dosage , Magnetics , Microscopy, Electron , Microspheres , Rats , Sarcoma, Yoshida/ultrastructure , Serum Albumin
17.
J Immunol ; 128(6): 2816-23, 1982 Jun.
Article in English | MEDLINE | ID: mdl-6804569

ABSTRACT

The capacity for augmented binding of tumor cells is an initial and necessary part of macrophage-mediated tumor cytotoxicity. To study the induction of binding capacity, we obtained FCS-elicited, inflammatory macrophages from C57BL/6J mice. Exposure of these macrophages to lymphokine(s) containing MAF induced augmented binding capacity in a dose-dependent fashion. Resident peritoneal macrophages did not respond to lymphokine, and endotoxin did not appreciably influence induction of binding. Maximum induction of binding required continuous interaction between macrophages and lymphokine for 6 to 10 hr. The conditions necessary for induction of binding closely paralleled those for induction of priming or cytolysis. Exposure of FCS-elicited macrophages from C3H/HeJ mice, although not of macrophages from A/J mice, induced augmented binding. The data suggest that the augmented capacity for binding tumor cells is induced by lymphokine(s) and that a major part of induction of priming for cytolysis by MAF is induction of such binding.


Subject(s)
Lymphokines/pharmacology , Lymphoma/immunology , Macrophage Activation , Mast-Cell Sarcoma/immunology , Animals , Binding Sites , Cytotoxicity, Immunologic , Dose-Response Relationship, Immunologic , Endotoxins/genetics , Endotoxins/pharmacology , Female , Kinetics , Lymphokines/genetics , Macrophage-Activating Factors , Mice , Mice, Inbred A , Mice, Inbred C3H , Mice, Inbred C57BL , Mice, Inbred DBA
18.
Fed Proc ; 41(6): 2212-21, 1982 Apr.
Article in English | MEDLINE | ID: mdl-6804274

ABSTRACT

Macrophages can be activated to kill neoplastic cells selectively and efficiently. Recent studies from his laboratory on mechanisms of target recognition and injury operative in such lysis have centered on the binding of tumor targets to the secretion of a cytolytic protease (cytolytic factor (CF]) by activated murine macrophages. Activated macrophages selectively and extensively bind neoplastic cells; nonselective binding of a low degree is seen between numerous cell pairs. The selective binding of three nonadherent tumors, which is much firmer than the nonselective binding, appears to depend on shared recognition structures contained within plasma membranes of the three tumors. Activated macrophages also secrete a potent, cytolytic, serine protease of molecular weight approximately 40,000. Secretion of CF is closely correlated with activation for cytolysis, and specific protease inhibitors of CF block macrophage-mediated cytotoxicity. Binding of tumor cells to activated macrophages triggers augmented secretion of CF. Several lines of evidence indicate that the capacity for selective binding and the capacity for secreting CF are separate and independently regulated functions of activated macrophages and that each is necessary but not sufficient for completion of macrophage-mediated tumor cytotoxicity. Analysis of the complete lytic interaction between activated macrophages and tumor cells suggests that binding and then secretion of CF are sequentially involved. These data have been integrated into a minimal hypothetical model, which suggests that macrophage-mediated tumor cytotoxicity is a multistep event encompassing 1) selective binding of tumor cells to the surface of activated macrophages and 2) secretion of multiple lytic effector substances, including CF, from the activated macrophages.


Subject(s)
Macrophages/immunology , Neoplasms/immunology , Animals , Cell Communication , Cell Membrane/metabolism , Cytotoxicity, Immunologic , Macrophage Activation , Macrophages/ultrastructure , Mast-Cell Sarcoma/immunology , Mice , Models, Biological , Neoplasms, Experimental/immunology
19.
J Exp Med ; 154(1): 77-87, 1981 Jul 01.
Article in English | MEDLINE | ID: mdl-6788893

ABSTRACT

The binding of tumor cells by activated macrophages is an initial and necessary event in the cytolysis of these targets. The data here indicate that membrane preparations from RL sigma 1 leukemia targets, EL-4 lymphoma targets, and P815 mastocytoma targets each inhibited binding of its homologous target to bacillus Calmette-Guérin (BCG)-activated murine macrophages in a dose-dependent fashion. Similar amounts of membrane from lymphocytes did not alter binding of the three neoplastic target to BCG-macrophages. Membranes of the three targets also inhibited binding of the heterologous neoplastic targets. Inhibitory activity of membrane preparations from P815, EL-4, and RL sigma 1 targets could be adsorbed by incubation of limiting concentrations of the membrane preparations with BCG-activated macrophages but not with thioglycollate broth-elicited macrophages. Exposure of BCG macrophages to membrane preparations from RL sigma 1, FL-4, or P815 targets inhibited subsequent cytolysis of the three targets. Inhibitory activity was increased in preparations enriched for plasma membrane. The data suggest that binding of three murine, nonadherent neoplastic targets to BCG-activated murine macrophages is mediated, in part, by recognition structures present within the plasma membranes of the three targets.


Subject(s)
Lymphoma/immunology , Macrophages/immunology , Adsorption , Animals , Binding Sites , Binding, Competitive , Cell Membrane/immunology , Cytotoxicity, Immunologic , Leukemia, Experimental/immunology , Mast-Cell Sarcoma/immunology , Mice , Mice, Inbred C57BL , Mycobacterium bovis/immunology
20.
J Immunol ; 126(5): 1843-7, 1981 May.
Article in English | MEDLINE | ID: mdl-6783698

ABSTRACT

Peritoneal macrophages from BCG-infected C3H/HeJ or A/J mice, in contrast to BCG-activated macrophages from C3H/HeN mice, were ineffective at lysing adherent 1023 sarcoma targets, nonadherent P815 mastocytoma targets, or nonadherent EL-4 lymphoma targets. The ability of macrophages from BCG-infected C3H/HeJ mice to secret cytolytic factor (CF) into the supernatant medium was markedly impaired. This secretory deficit, however, did not extend to plasminogen activator, secretion of which was augmented. In contrast, the ability of BCG macrophages from A/J mice to secrete CF was comparable to or even slightly higher than that of macrophages from C3H/HeN mice. The ability of BCG-elicited macrophages from A/J mice to bind either of 2 neoplastic targets (the P815 mastocytoma and the EL-4 lymphoma), however, was greatly reduced. The ability of BCG-elicited macrophages from C3H/HeJ mice to bind these targets was comparable to that of macrophages from C3H/HeN mice. The data suggest that the phenotypically-similar deficits in tumoricidal capacity of BCG-elicited macrophages from C3H/HeJ and A/J mice are mediated by mechanistically different defects in macrophage-tumor cell interactions.


Subject(s)
Cytotoxicity, Immunologic , Macrophages/immunology , Neoplasms, Experimental/metabolism , Sarcoma, Experimental/genetics , Animals , Binding Sites , Cells, Cultured , Endotoxins/pharmacology , Lymphoma/metabolism , Mast-Cell Sarcoma/metabolism , Mice , Mice, Inbred A , Mice, Inbred C3H , Mycobacterium bovis/immunology , Plasminogen Activators/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...